A couple of months ago, I was relieved to note that both Presidential candidates were backing away from drug importation into the
Unfortunately, former Senate Majority Leader Tom Daschle, who has been nominated by President-elect Obama to head the Department of Health and Human Services, is a big fan of importation.
Check out Senator Daschle’s 2004 Op-Ed Health-care system picks winners and losers, in which he states:
Second, to lower drug costs, we can pass bipartisan legislation supported by Republicans John McCain and
FYI, he is referring to his co-sponsorship of the 2004 Senate importation bill (S.2328), which didn’t get very far. He was no longer in the Senate by the time the 2007 version (S.242 Pharmaceutical Market Access and Drug Safety Act of 2007) came along, so he could not join then-Senator Obama in supporting this bill.
The conventional wisdom suggests that the contaminated heparin incident, among other things, has pushed drug importation off the radar screen. But I’m not so sure given Sen. Daschle’s many, many public pro-importation comments over the years. And some groups, such as wholesalers, will potentially benefit from legalized importation, as I note in Drug Importation and Global Wholesale.
Stay tuned for Part XIII...----